Skip to main content

Table 1 Outcome measures

From: Efficacy and safety of Tengfu Jiangya tablet combined with valsartan/amlodipine in the treatment of stage 2 hypertension: study protocol for a randomized controlled trial

Domain Measurement Time (days)
Primary outcomes
 msSBP/msDBP Three consecutive sitting BP measurements will be performed at 3-min intervals, and the average of three measurements will be used as a reference for each patient’s msSBP and msDBP. 0, 3, 14, 21, 28
Secondary outcomes
 BP control rate Defined as msSBP/msDBP < 140/90 mmHg 28
 TCM syndrome scoring TCM syndrome scoring scale will be used for evaluating the improvement of symptoms (Additional file 3). 0,28
Biochemical index
 Blood lipids On days 0 and 28 of the treatment cycle, the researchers will collect the morning fasting blood of each subject for biochemical detection. 0,28
 Blood sugar
 Urine microalbumin
 Uric acid
 Homocysteine
 C-reactive protein